19 March 2020
The recent unavailability of Sinemet CR® has affected many people with Parkinson's.
Merck Sharp and Dohne Pty Ltd has arranged supply of an alternative product to replace Sinemet CR®. This product is listed on the Australian PBS and can be prescribed for patients under Section 19A of the Therapeutic Goods Act 1989.
The product should be prescribed as:
"SINEMET CR 50mg/ 200mg Prolonged-Release Tablet"
It is supplied in packs of 60 tablets. Instructions for how to prescribe this product are detailed in the following document from MSD.
Prescribers may find it useful to provide patients with a copy of this document with the script, in case the dispensing pharmacist is unaware of this formulation or how to order it.